Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
Critical Care (London, England)
|
December 12, 2022
Ultra-lung-protective ventilation and biotrauma in severe ARDS patients on veno-venous extracorporeal membrane oxygenation: a randomized controlled study
Christophe Guervilly, Théotime Fournier, Juliette Chommeloux, et al.
The Journal of Infectious Diseases
|
August 20, 2020
Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19
Christophe Guervilly, Stephane Burtey, Florence Sabatier, et al.
Intensive Care Medicine
|
June 22, 2016
Lung ultrasonography for assessment of oxygenation response to prone position ventilation in ARDS
Malik Haddam, Laurent Zieleskiewicz, Sebastien Perbet, et al.
JAMA
|
October 11, 2013
Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial
Laurent Papazian, Antoine Roch, Pierre-Emmanuel Charles, et al.
Frontiers in Immunology
|
January 30, 2025
Caspase-1 activation, IL-1/IL-6 signature and IFNγ-induced chemokines in lungs of COVID-19 patients
Audrey Cambon, Christophe Guervilly, Clémence Delteil, et al.
Nature
|
July 30, 2020
Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis
Julien Carvelli, Olivier Demaria, Frédéric Vély, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 9, 2022
Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome Associated with COVID-19: An Emulated Target Trial Analysis
David Hajage, Alain Combes, Christophe Guervilly, et al.
The New England Journal of Medicine
|
May 24, 2018
Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome
Alain Combes, David Hajage, Gilles Capellier, et al.
Critical Care Medicine
|
October 11, 2022
Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE])
Julien Carvelli, Ferhat Meziani, Jean Dellamonica, et al.
Critical Care (London, England)
|
October 10, 2024
Extracorporeal membrane oxygenation for tuberculosis-related acute respiratory distress syndrome: An international multicentre retrospective cohort study
Ali Ait Hssain, Matthieu Petit, Clemens Wiest, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
Critical Care (London, England)
|
December 12, 2022
Ultra-lung-protective ventilation and biotrauma in severe ARDS patients on veno-venous extracorporeal membrane oxygenation: a randomized controlled study
Christophe Guervilly, Théotime Fournier, Juliette Chommeloux, et al.
The Journal of Infectious Diseases
|
August 20, 2020
Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19
Christophe Guervilly, Stephane Burtey, Florence Sabatier, et al.
Intensive Care Medicine
|
June 22, 2016
Lung ultrasonography for assessment of oxygenation response to prone position ventilation in ARDS
Malik Haddam, Laurent Zieleskiewicz, Sebastien Perbet, et al.
JAMA
|
October 11, 2013
Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial
Laurent Papazian, Antoine Roch, Pierre-Emmanuel Charles, et al.
Frontiers in Immunology
|
January 30, 2025
Caspase-1 activation, IL-1/IL-6 signature and IFNγ-induced chemokines in lungs of COVID-19 patients
Audrey Cambon, Christophe Guervilly, Clémence Delteil, et al.
Nature
|
July 30, 2020
Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis
Julien Carvelli, Olivier Demaria, Frédéric Vély, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 9, 2022
Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome Associated with COVID-19: An Emulated Target Trial Analysis
David Hajage, Alain Combes, Christophe Guervilly, et al.
The New England Journal of Medicine
|
May 24, 2018
Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome
Alain Combes, David Hajage, Gilles Capellier, et al.
Critical Care Medicine
|
October 11, 2022
Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE])
Julien Carvelli, Ferhat Meziani, Jean Dellamonica, et al.
Critical Care (London, England)
|
October 10, 2024
Extracorporeal membrane oxygenation for tuberculosis-related acute respiratory distress syndrome: An international multicentre retrospective cohort study
Ali Ait Hssain, Matthieu Petit, Clemens Wiest, et al.
Page
of 10